Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc S Raab

Showing results (61-70 of 177) with videos related to

Pageof 18
Sort By:
Cancer Research|February 20, 2007
Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myelomaKlaus Podar, Marc S Raab, Giovanni Tonon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 21, 2025
Correction to: Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [<sup>18</sup>F]FDG PET/CT predicts survival in multiple myelomaChristos Sachpekidis, Olof Enqvist, Johannes Ulén, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 8, 2024
Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [<sup>18</sup>F]FDG PET/CT predicts survival in multiple myelomaChristos Sachpekidis, Olof Enqvist, Johannes Ulén, et al.
Leukemia|May 17, 2019
The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myelomaMarc S Raab, Sheeba K Thomas, Enrique M Ocio, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 11, 2024
Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myelomaSarah Schreiner, Natalie Berghaus, Alexandra M Poos, et al.
Bone Marrow Transplantation|March 14, 2024
Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in GermanySandra Sauer, Monika Engelhardt, Karolin Trautmann-Grill, et al.
Journal of Hematology & Oncology|June 28, 2019
Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trialDirk Hose, Susanne Beck, Hans Salwender, et al.
European Radiology|November 28, 2024
Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myelomaChristian Neelsen, Christos Sachpekidis, Lukas John, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 30, 2022
Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple MyelomaFredrik Schjesvold, Bruno Paiva, Vincent Ribrag, et al.
Blood|November 20, 2008
Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signalingMarc S Raab, Iris Breitkreutz, Giovanni Tonon, et al.
Pageof 18

Showing results (61-70 of 177) with videos related to

Sort By:
Pageof 18
Cancer Research|February 20, 2007
Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myelomaKlaus Podar, Marc S Raab, Giovanni Tonon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 21, 2025
Correction to: Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [<sup>18</sup>F]FDG PET/CT predicts survival in multiple myelomaChristos Sachpekidis, Olof Enqvist, Johannes Ulén, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 8, 2024
Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [<sup>18</sup>F]FDG PET/CT predicts survival in multiple myelomaChristos Sachpekidis, Olof Enqvist, Johannes Ulén, et al.
Leukemia|May 17, 2019
The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myelomaMarc S Raab, Sheeba K Thomas, Enrique M Ocio, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 11, 2024
Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myelomaSarah Schreiner, Natalie Berghaus, Alexandra M Poos, et al.
Bone Marrow Transplantation|March 14, 2024
Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in GermanySandra Sauer, Monika Engelhardt, Karolin Trautmann-Grill, et al.
Journal of Hematology & Oncology|June 28, 2019
Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trialDirk Hose, Susanne Beck, Hans Salwender, et al.
European Radiology|November 28, 2024
Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myelomaChristian Neelsen, Christos Sachpekidis, Lukas John, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 30, 2022
Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple MyelomaFredrik Schjesvold, Bruno Paiva, Vincent Ribrag, et al.
Blood|November 20, 2008
Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signalingMarc S Raab, Iris Breitkreutz, Giovanni Tonon, et al.
Pageof 18